• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

河南省城市地区肝癌筛查的依从率及影响因素分析

[Compliance rate and impact factor analysis of liver cancer screening in urban areas of Henan Province].

作者信息

Guo L W, Zhang S K, Liu S Z, Zheng L Y, Chen Q, Cao X Q, Sun X B, Zhang J G

机构信息

Henan Office for Cancer Control and Research, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2021 Feb 23;43(2):233-237. doi: 10.3760/cma.j.cn112152-20200331-00286.

DOI:10.3760/cma.j.cn112152-20200331-00286
PMID:33601491
Abstract

To evaluate the compliance rate and its impact factors of liver cancer screening for high-risk groups in urban areas of Henan Province from 2013 to 2019. Residents of 40-74 years old in 8 cities of Henan province were selected to investigate the risk factors and liver cancer risk assessment. Subjects with high risk of liver cancer received AFP combined ultrasonography for screening. Chi-square tests were used to compare the differences in liver cancer screening participation rates between groups. Multivariate logistic regression models were applied to explore the potential factors correlating to the compliance of liver cancer screening. Overall, 3 6781 participants who met the inclusion criteria were included in this analysis, and 17 241 of them took the following liver cancer screening, yielding a participation rate of 46.87%. The participation rate varied greatly across cities, ranging from 62.50% to 38.59%. Moreover, the participation rate varied greatly across periods, ranging from 52.77% in 2014-2015 to 38.14% in 2013-2014. The multivariate Logistic regression analyses showed that: female, older, high education degree, cigarette and alcohol intake, infrequent physical exercise, chronic hepatitis B, chronic hepatitis C, fatty liver, gallstones and a family history of liver cancer were inclined to accept liver cancer screening (<0.05). The overall participation rate of liver cancer screening among high-risk population is less than 50% in urban areas of Henan Province. Implement of effective interventions targeting the specific high-risk populations might improve the overall compliance rate of liver cancer screening in the future.

摘要

评估2013年至2019年河南省城市地区高危人群肝癌筛查的依从率及其影响因素。选取河南省8个城市40 - 74岁的居民,调查其危险因素及肝癌风险评估情况。肝癌高危受试者接受甲胎蛋白联合超声检查进行筛查。采用卡方检验比较各组肝癌筛查参与率的差异。应用多因素logistic回归模型探讨与肝癌筛查依从性相关的潜在因素。总体而言,本分析纳入了36781名符合纳入标准的参与者,其中17241人进行了后续的肝癌筛查,参与率为46.87%。各城市的参与率差异很大,从62.50%到38.59%不等。此外,不同时期的参与率差异也很大,从2014 - 2015年的52.77%到2013 - 2014年的38.14%不等。多因素logistic回归分析显示:女性、年龄较大、文化程度高、吸烟饮酒、缺乏体育锻炼、慢性乙型肝炎、慢性丙型肝炎、脂肪肝、胆结石及肝癌家族史者更倾向于接受肝癌筛查(P<0.05)。河南省城市地区高危人群肝癌筛查的总体参与率不到50%。针对特定高危人群实施有效的干预措施可能会提高未来肝癌筛查的总体依从率。

相似文献

1
[Compliance rate and impact factor analysis of liver cancer screening in urban areas of Henan Province].河南省城市地区肝癌筛查的依从率及影响因素分析
Zhonghua Zhong Liu Za Zhi. 2021 Feb 23;43(2):233-237. doi: 10.3760/cma.j.cn112152-20200331-00286.
2
[Compliance of lung cancer screening with low-dose computed tomography and influencing factors in urban area of Henan province].[河南省城市地区肺癌低剂量计算机断层扫描筛查的依从性及影响因素]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Jul 10;41(7):1076-1080. doi: 10.3760/cma.j.cn112338-20190730-00564.
3
[Analysis of endoscopic screening compliance and related factors among high risk population of upper gastrointestinal cancer in urban areas of Henan Province from 2013 to 2017].[2013年至2017年河南省城市地区上消化道癌高危人群内镜筛查依从性及相关因素分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 May 6;54(5):523-528. doi: 10.3760/cma.j.cn112150-20200304-00238.
4
[Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].[中国城市结直肠癌高危人群筛查结肠镜检查的依从率及其相关因素]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Mar 6;52(3):231-237. doi: 10.3760/cma.j.issn.0253-9624.2018.03.004.
5
[A comparative analysis of the distribution of the high-risk population of upper gastrointestinal cancer and endoscopic screening compliance in two urban areas and two rural areas in China].[中国两个城市地区和两个农村地区上消化道癌高危人群分布及内镜筛查依从性的对比分析]
Zhonghua Zhong Liu Za Zhi. 2022 Jun 23;44(6):531-539. doi: 10.3760/cma.j.cn112152-20210916-00707.
6
[Analysis of detection rate and compliance of colorectal cancer screening with colonoscopy in urban areas of Henan Province, 2013-2019].[2013 - 2019年河南省城市地区结肠镜检查用于结直肠癌筛查的检出率及依从性分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Mar 6;55(3):353-358. doi: 10.3760/cma.j.cn112150-20200304-00242.
7
[Detection of colorectal advanced neoplasms among the cancer screening population in urban areas of Henan Province and analysis on its influencing factors].[河南省城市地区癌症筛查人群中结直肠进展性腺瘤的检测及其影响因素分析]
Zhonghua Zhong Liu Za Zhi. 2024 Aug 23;46(8):794-800. doi: 10.3760/cma.j.cn112152-20231026-00272.
8
[Analysis of liver cancer screening results and influencing factors of urban residents in Zhejiang Province from 2013 to 2018].2013年至2018年浙江省城市居民肝癌筛查结果及影响因素分析
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Mar 6;55(3):346-352. doi: 10.3760/cma.j.cn112150-20200818-01132.
9
[Results of the cancer screening program in urban areas in Shaanxi province of China, 2019-2020].[2019 - 2020年中国陕西省城市地区癌症筛查项目结果]
Zhonghua Zhong Liu Za Zhi. 2024 Oct 23;46(10):948-953. doi: 10.3760/cma.j.cn112152-20231020-00208.
10
[Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].[2013 - 2018年浙江省城市居民结直肠癌筛查项目的结果与成本效益]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Dec 10;41(12):2080-2086. doi: 10.3760/cma.j.cn112338-20200324-00424.

引用本文的文献

1
Temporal trends of incidence, mortality, and survival of liver cancer during 2011-2020 in Fujian Province, Southeast China.2011 - 2020年中国东南部福建省肝癌发病率、死亡率及生存率的时间趋势
Arch Public Health. 2024 Dec 4;82(1):233. doi: 10.1186/s13690-024-01462-7.
2
Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population.甲基化 SEPT9 联合 AFP 和 PIVKA-II 可有效检测高危人群 HCC。
BMC Gastroenterol. 2023 Jul 31;23(1):260. doi: 10.1186/s12876-023-02900-6.
3
Gender survival differences in hepatocellular carcinoma: Is it all due to adherence to surveillance? A study of 1716 patients over three decades.
肝细胞癌的性别生存差异:这一切都归因于对监测的依从性吗?一项对1716例患者长达三十年的研究。
JGH Open. 2023 Apr 24;7(5):377-386. doi: 10.1002/jgh3.12910. eCollection 2023 May.